<div id="readability-page-1"><div>** Shares of biopharmaceutical products developer 3SBio Inc slip 5.4% to HK$29.98, their lowest level since November 24** Stock on course for the biggest one-day pct drop since November 21; top pct loser in Hang Seng Composite Index tracking healthcare stocks (.HSCIH), which is down 1%** 3SBio plans sale of 105.17 mln new shares to third paty investors in share placement, raising HK$3.12 billion ($400.49 million) for advancing clinical research in China and the United States on innovative drug candidates in the R&amp;D stage to accelerate pipeline progress, among others** The new shares will be issued at HK$29.62 apiece, or a 6.5% discount to Monday close of HK$31.68 each ** YTD, stock up 397%, Hang Seng Biotech Index up 80.1%($1 = 7.7904 Hong Kong dollars)</div></div>

01530

3SBio Inc's shares dropped 5.4% to HK$29.98, marking the largest one-day percentage drop since November 21. The company plans to sell 105.17 million new shares at a 6.5% discount to raise HK$3.12 billion for clinical research in China and the US. Despite the drop, the stock is up 397% YTD, while the Hang Seng Biotech Index is up 80.1%.

HK-listed 3SBIO slips on discounted share sale